Evidence map›Paper›PMID 39382900›Full record

Trial reportJAMA network open2024

Mindfulness Meditation vs Escitalopram for Treatment of Anxiety Disorders: Secondary Analysis of a Randomized Clinical Trial.

Hiroe Hu, Mihriye Mete, Neil K Rustgi, Charisma I Washington, Kavya Sanghavi, Mary Ann Dutton, Naomi M Simon, Amanda W Baker, Eric Bui, Elizabeth A Hoge

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hiroe HuExperimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland.
Mihriye MeteMedstar Health Research Institute, Hyattsville, Maryland.
Neil K RustgiDepartment of Psychiatry, Georgetown University Medical Center, Washington, DC.
Charisma I WashingtonDepartment of Psychiatry, Georgetown University Medical Center, Washington, DC.
Kavya SanghaviMedstar Health Research Institute, Hyattsville, Maryland.
Mary Ann DuttonDepartment of Psychiatry, Georgetown University Medical Center, Washington, DC.
Naomi M SimonDepartment of Psychiatry, NYU Grossman School of Medicine, New York.
Amanda W BakerDepartment of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Eric BuiCaen University Hospital, University of Caen Normandy, Caen, France.
Elizabeth A HogeDepartment of Psychiatry, Georgetown University Medical Center, Washington, DC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anxiety DisordersEscitalopramMeditationMindfulnessAdultCitalopramFemaleHumansMaleMiddle AgedSelective Serotonin Reuptake InhibitorsTreatment OutcomeCitalopramEscitalopramSelective Serotonin Reuptake Inhibitors

Identifiers

PMID39382900
PMCPMC11581486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.